
This article reports on Eli Lilly’s February 2025 price reduction for higher-dose Zepbound (tirzepatide) vials through their direct-to-consumer program. The strategy targets patients without insurance coverage for weight loss medications, particularly Medicare recipients, and those who previously used compounded tirzepatide. The article explains pricing, administration differences, and regulatory context.
Key Clinical Considerations
- Lilly now offers 7.5mg and 10mg Zepbound vials at $499/month with timely refills (increasing to $599-$699 otherwise), plus reduced prices on 2.5mg ($349) and 5mg ($499) doses.
- Self-administered vials require patients to use needle and syringe rather than auto-injector pens, necessitating patient education on proper technique.
- The FDA’s December 2024 resolution of tirzepatide shortages eliminated the legal basis for compounded versions, though this decision faced legal challenges from compounding pharmacy groups.
- Patients transitioning from compounded to FDA-approved tirzepatide may experience different side effects due to formulation variations between products.
- Approximately 10% of new Zepbound users enroll in the self-pay program, including former compounded tirzepatide users seeking continued treatment.
Clinical Practice Impact
- Patient Communication: Clinicians should discuss injection technique with patients using vials instead of auto-injectors, including site selection and comfort measures (eg, ice for numbing).
- Cost Counseling: Providers should prepare patients for potential “sticker shock” when transitioning from compounded to FDA-approved versions, and evaluate affordability barriers.
- Monitoring Transitions: Patients switching between compounded and branded tirzepatide may require closer monitoring for different side effect profiles.
- Prescription Continuity: Providers should ensure timely prescriptions as the pricing model incentivizes refills within 45 days ($499 vs. $599-$699 monthly).
- Comprehensive Care: As noted by Dr. Vasagar, clinicians should integrate medication management with lifestyle modification guidance for sustainable weight management.
More on Healthcare Costs